BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Discover various ways to increase your cash back rewards and enhance your overall savings strategy. Start maximizing your benefits now!
23,199 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
SpaceX's planned IPO has drawn record demand, but market watchers warn buyers to scrutinize the order book for true d...
North Dakota is quietly attracting retirees thanks to affordability, space, and simpler living, even as cold winters ...
Feeling weary from stock swings? This practical guide offers a safer, simpler investment path using broad-market fund...
AI is reshaping the data center landscape, and Marvell is at the center of the action. This piece breaks down why mar...
Beyond Meat faces headwinds, but a protein drinks turnaround catalyst could change the game. This article breaks down...
As oil and stock markets swing on headlines, this explainer breaks down how futures contracts work? and why they matt...
Boards of public homebuilders are treating scale as a fiduciary test, a shift highlighted by Berkshire Hathaway's Tay...
Is it time to move on from Cardano? This article explains three concrete reasons to consider selling Cardano today an...
If you’re playing the long game, XRP could ride a growing payments ecosystem, regulatory clarity, and broader crypto ...
Investing in memory chips means weighing volatility against opportunity. This article digs into could micron technolo...
Rivian is under renewed investor scrutiny as the R2 launch tests demand and governance structure limits shareholder i...